A National Cancer Clinical Trials System for the 21st Century
Reinvigorating the NCI Cooperative Group Program
Institute of Medicine author Board on Health Care Services author Committee on Cancer Clinical Trials and the NCI Cooperative Group Program author Harold L Moses editor Sharyl J Nass editor John Mendelsohn editor
Format:Paperback
Publisher:National Academies Press
Published:8th Aug '10
Currently unavailable, and unfortunately no date known when it will be back
The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.
Table of Contents- Front Matter
- Executive Summary
- Overview of Conclusions and Recommendations
- 1 Introduction
- 2 The Science of Developing Cancer Therapy
- 3 Operations, Oversight, and Funding of Cancer Clinical Trials
- 4 Physician and Patient Participation in Cancer Clinical Trials
- Appendix A: Previous and Ongoing Analyses Undertaken by NCI
- Appendix B: Committee Member and Staff Biographies
- Acronyms
- Glossary <
ISBN: 9780309151863
Dimensions: unknown
Weight: unknown
316 pages